CLINICALLY VALIDATED REGENERATION, BUILT FOR ELITE PERFORMERS.
Designed for recovery under sustained physical demand. Powered by Dezawa MuseCell® Technology.
Dezawa IV therapies are licensed, cell-based regenerative interventions developed from more than a decade and a half of peer-reviewed research on Dezawa MuseCells®.
Because some forms of damage accumulate faster than the body can recover on its own — and when recovery windows are limited, durability matters as much as speed.
QUICK RECOVERY THAT PROTECTS YOUR LONG GAME.
Recover faster, perform longer, and stay durable under extreme demand.
Dezawa MuseCells® are studied for stress resistance and tissue integration, supporting repair and long-term regeneration while maintaining the structural integrity required for durable, high-functioning tissue.
Accelerated Recovery
Get back to it, quicker. Faster healing IV therapy enables you to rebound from high-intensity training, competitions, or operations, so you can safely get back to training or return to duty.
Structural Durability
Resilience where your body takes the most damage. Enhanced targeting and distribution helps maintain the integrity of muscles, joints, tendons, and connective tissue under chronic load.
Inflammation & Stress Response
Don’t just be ready—be elite. Performance recovery IV therapy that supports high-load training and competition by naturally homing to micro-damaged sites for tissue repair and vascular integrity.
Sustained Readiness
Not just weeks or months—this is support that holds up. IV therapy for strength designed for athletes and warfighters who expect high output over years, with lasting therapeutic effects for repeatable performance over a season or career.
DEZAWA RESTORE + REGENESIS IV THERAPIES
Regenerative IV therapies designed for high-demand recovery and durability.
Dezawa MuseCells® are clinically studied cells selected for stress resistance and targeted tissue support. Unlike conventional MSC-based infusions, Dezawa IV therapies utilize Dezawa MuseCells uniquely studied for stress resistance, safety, and regenerative activity under physiologic demand.
Instead of getting trapped in the lungs, Dezawa MuseCells® have been studied for their ability to remain viable in circulation so you can count on effective treatment in the areas that require support.
DEZAWA RESTORE IV™
Dezawa MuseCells®
Powered by Dezawa MuseCells®, prepared through licensed, high-purity processes to deliver consistent, performance-ready regenerative support.
Designed for individuals operating under ongoing load who require reliable recovery support and long-term durability.
- Supports accelerated recovery following high-intensity training or competition
- Helps maintain tissue integrity in areas exposed to repeated stress
- Intended to support durability and reduce cumulative breakdown over time
DEZAWA REGENeSIS IV™
Dezawa MuseCells® and Dezawa MuseExosomes®
Dezawa Regenesis IV™ builds on the Restore foundation with the addition of MuseExosomes®, and is applied in contexts requiring a higher level of regenerative support — including injury, pain, or accumulated tissue trauma.
This therapy is reserved for higher-intensity recovery needs where inflammation control, tissue stabilization, and regenerative signaling play a more central role.
- Includes the core performance and durability benefits of the Restore IV
- Enhanced coordination for inflammation control, tissue stabilization, and regeneration
- Enhanced signaling and efficacy using Dezawa MuseExosomes® to optimize the healing environment.
WHEN RECOVERY CAN’T WAIT
High-performance recovery that’s as fast, resilient, and relentless as the demands you face.





THE LICENSING AUTHORITY BEHIND AUTHENTIC DEZAWA MUSECELLS®
More than an MSC. Evidence-based IV infusion science backed by 85+ peer-reviewed studies, 120+ publications, and over a decade and a half of research.
THE MILITARY’S BIGGEST READINESS DRAIN
Musculoskeletal injuries and mild TBIs account for the majority of non-deployable service members, driving an estimated $3–4B in annual costs, primarily from lost duty time.
INJURIES COST PRO SPORTS OVER $3 BILLION EVERY YEAR
This recurring loss reflects missed games, reduced performance, and a massive opportunity to improve athlete durability and recovery.
MUSECELL INNOVATIONS® X AXIS BIOVENTURES
“MuseCell Innovations® (MCI) and Axis BioVentures (ABV) have partnered to lead innovative regenerative medicine and research programs in support of the warfighter and Special Operations Forces (SOF). The programs will focus on the future of accelerated healing, return to duty, and regenerative medicine products and methods to guide an industry on best practices and products to serve the veteran and active-duty SOF community.”
WHEN RECOVERY
NEVER FULLY RESETS
At the elite level, performance loss rarely comes from a single injury. It comes from accumulated tissue stress that compounds across seasons, training blocks, and competition cycles.
WHEN ACCUMULATION
BECOMES RISK
In high-stakes operational settings, fatigue, impact, and cognitive load don’t resolve cleanly between missions. Recovery decisions directly affect readiness, safety, and long-term capability.
GUIDED BY EXPERIENCE
Developed with input from world class scientific advisors, clinicians, and industry experts to ensure integrity, safety, and performance alignment.
Kevin Serre, PHD
President, Dezawa High Performance
President, Dezawa High Performance
Kevin Serre, PHD
Kevin Serre, PH.D., is the President of Dezawa High Performance™ (DHP), a wholly owned subsidiary of MuseCell Innovations® PTD LTD. As President of DHP, Kevin is responsible for the application of MCI technology with their professional sport and elite Military partners. Kevin formerly worked as the Human Performance lead for the Canadian Department of Defense’s Canadian Special Operations Forces Command (CANSOFCOM).
Dr. Dominik Duscher, MD, PhD
Chief Medical Officer
Chief Medical Officer
Dr. Dominik Duscher, MD, PhD
Dominik Duscher MD PhD is a specialist in longevity medicine and plastic surgery, a scientist, bestselling author, consultant and entrepreneur. After studying at the Medical University of Vienna, University College London and Harvard Medical School, he completed a postdoctoral fellowship in Stem Cell Biology and Regenerative Medicine at Stanford University. From 2017-2020, Dr. Duscher was Director of the Research Department for Plastic Surgery at the Technical University of Munich.
His research focus is the optimization of cell function in old age and diabetes. He holds several patents, has published more than 160 scientific papers and has written bestsellers in regenerative medicine and aging research. His research on skin and hair regeneration led to the founding of multiple biotech companies. He is director and owner of the Longevity Centre Munich, the first facility in Europe for institutionalized longevity medicine. Currently, Dr. Duscher is the Chief Scientific Officer at Tomorrow Labs.
Dr. Jonathan L. Glashow, M.D.
Board-Certified Orthopedic Surgeon,
Clinical Associate Professor, Sports Medicine Specialist
Board-Certified Orthopedic Surgeon,
Clinical Associate Professor, Sports Medicine Specialist
Dr. Jonathan L. Glashow, M.D.
Dr. Jonathan L. Glashow is a distinguished board-certified orthopedic surgeon with over four decades of clinical and surgical experience, widely recognized for his expertise in sports medicine and complex joint care. He serves as a Clinical Associate Professor in the Department of Orthopedic Surgery at NYU Grossman School of Medicine and maintains an active surgical practice in New York City.
Dr. Glashow’s clinical focus includes advanced arthroscopic and minimally invasive surgical techniques for shoulder and knee conditions, such as anterior cruciate ligament (ACL) reconstruction, revision ACL surgery, arthroscopic rotator cuff repair, meniscal transplantation, and other intricate procedures that optimize functional recovery and help patients return to active lifestyles. His individualized, precision-based surgical philosophy prioritizes rapid recovery and comprehensive post-operative coordination with rehabilitation professionals.
A trusted expert to elite athletes and active individuals, Dr. Glashow has been consulted nationally for his insights on injury treatment and recovery strategies and has appeared on major broadcast platforms. He has been featured in prominent publications and recognized repeatedly among America’s Top Doctors and New York Metro Area’s Best Doctors by Castle Connolly and New York Magazine.
Dr. Glashow earned his medical degree from Cornell University Medical College (1984) and completed orthopedic surgery residency training at Lenox Hill Hospital in New York City. He supplemented his surgical training with specialized fellowships in sports medicine and arthroscopic surgery at the Southern California Orthopaedic Institute/UCLA, followed by advanced shoulder fellowships in Canada and at the University of Texas Health Science Center at San Antonio.
His professional affiliations include the American Academy of Orthopaedic Surgeons, Arthroscopic Association of North America, and multiple national sports medicine societies. Dr. Glashow continues to contribute to the field through clinical practice, mentorship, and academic engagement, advancing care in orthopedic surgery and sports-related musculoskeletal injuries.
Duncan French
Sports Advisory Board Member,
SVP UFC Performance Institute
Sports Advisory Board Member,
SVP UFC Performance Institute
Duncan French
As the Senior Vice President (SVP) of the UFC Performance Institute since 2017, Duncan is responsible for directing high performance services to over 700 world-class MMA fighters globally and managing a team of 68 high performance service providers across 3 world-class facilities in Las Vegas, Shanghai, and Mexico City.
Andy O’Brien
Sports Advisory Board Member
Sports Advisory Board Member
Andy O’Brien
Andy O’Brien is a strength and conditioning coach with three decades of experience in professional and Olympic sport. He is recognized for his work with iconic athletes across multiple disciplines and for his diverse leadership roles within high-performing organizations, including four Stanley Cup–winning teams.
Rob Lively
Chair, Military Advisory Board
Chair, Military Advisory Board
Rob Lively
Retired U.S. Army Command Sergeant Major with 28 years of experience leading
elite, high-performance organizations within U.S. Army Special Operations. He
served in the Army’s most selective units, advising senior military and government
leaders on strategy, risk, and execution in complex global environments. Rob was
instrumental in the design and execution of enterprise-level human performance
initiatives, driving measurable improvements in performance, resilience, and
organizational readiness.
Today, Rob serves as a board advisor, professional speaker, and business
consultant, working with leadership teams across multiple industries to strengthen
organizational performance, decision-making, and culture under pressure. He is
actively building an entrepreneurial portfolio through investments in
owner-operator businesses and brings a disciplined, outcomes-focused approach to
governance, growth, and talent development. Rob is currently enrolled in the
Strategic Leadership Executive MBA Program at The University of Tennessee.
Dr. Kenneth M. Ford
Founder & CEO Emeritus
Institute for Human & Machine Cognition (IHMC)
Founder & CEO Emeritus
Institute for Human & Machine Cognition (IHMC)
Dr. Kenneth M. Ford
Kenneth Ford is Founder and Chief Executive Officer of the Florida Institute for Human & Machine Cognition (IHMC) — a not-for-profit research institute located in Pensacola, Florida. IHMC has grown into one of the nation’s premier research organizations with world-class scientists and engineers investigating a broad range of topics related to building technological systems aimed at amplifying and extending human cognition, perception, locomotion, and resilience. Richard Florida has described IHMC as “a new model for interdisciplinary research institutes that strive to be both entrepreneurial and academic, firmly grounded and inspiringly ambitious.” IHMC headquarters are in Pensacola with a branch research facility in Ocala, Florida. Ford is the author of hundreds of scientific papers and six books. Ford received his Ph.D. in Computer Science from Tulane University. He is Emeritus Editor-in-Chief of AAAI/MIT Press and has been involved in the editing of several journals. Ford is a Fellow of the Association for the Advancement of Artificial Intelligence, a charter Fellow of the National Academy of Inventors, a member of the Association for Computing Machinery, a member of the IEEE Computer Society, and a Fellow of the American Association for the Advancement of Science.
In January 1997, Ford was asked by NASA to develop and direct its new Center of Excellence in Information Technology at the Ames Research Center in Silicon Valley. He served as Associate Center Director and Director of NASA’s Center of Excellence in Information Technology. In July 1999, Ford was awarded the NASA Outstanding Leadership Medal. That same year, Ford returned to private life and to the IHMC.
In October of 2002, Ford was nominated to serve on the National Science Board (NSB) and the United States Senate confirmed his nomination in March of 2003. The NSB is the governing board of the National Science Foundation (NSF) and plays an important role in advising the President and Congress on science policy issues. In 2005, Ford was appointed and sworn in as a member of the Air Force Science Advisory Board. In 2007, he became a member of the NASA Advisory Council and on October 16, 2008, Ford was named as Chairman – a capacity in which he served until October 2011. In February of 2012, Ford was named to a two-year term on the Defense Science Board (DSB). In 2013, he became a member of the Advanced Technology Board which supports the Office of the Director of National Intelligence (ODNI). In 2018, Dr. Ford was appointed to the National Security Commission on Artificial Intelligence.
Ford has received many awards and honors. In 2004 Florida Trend Magazine named Ford one of Florida’s four most influential citizens working in academia. The University of Bordeaux awarded the Doctor Honoris Causas in 2005. In 2008 the Association for the Advancement of Artificial Intelligence (AAAI) award Ford the Robert S. Englemore Memorial Award for his work in artificial intelligence. In August 2010, Ford was awarded NASA’s Distinguished Public Service Medal – the highest honor the agency confers. In 2012 Tulane University named Ford its Outstanding Alumnus in the School of Science and Engineering. In 2015, AAAI named Ford the recipient of the 2015 Distinguished Service Award. Also, in 2015, he was elected as Fellow of the American Association for the Advancement of Science (AAAS). In 2017 Ford was inducted into the Florida Inventor’s Hall of Fame. In 2020, Florida Trend Magazine named Ford one of its Living Legends, a list of all-time influential Florida leaders in business, medicine, academia, entertainment, politics, and sport.
Alex R. Oliver
Military Advisory Board Member
Military Advisory Board Member
Alex R. Oliver
Alexander R. Oliver is a retired Navy SEAL with over 21 years of distinguished service, including leadership roles at the Naval Special Warfare Development Group (NSWDG) where he selected, trained and mentored the next generation of America’s most elite warrior athletes. As the founder of Virginia High Performance LLC (VHP), Alex has been instrumental in advancing human performance and rehabilitation programs for elite military personnel and veterans. He pioneered initiatives such as the Human Performance Program at NSWDG and the “Continue Mission” program at VHP, which leverages science and holistic based research and modalities to deliver programs specifically to meet each veteran’s goals and needs. His work has directly contributed to US Special Operations Command (SOCOM) efforts like the Preservation of the Force and Family (POTFF) and he has supported the recovery and readiness of over 1,600 active duty personnel and veterans.
Ed Sanders, CGC
Military Advisory Board Member
Military Advisory Board Member
Ed Sanders, CGC
Ed Sanders joined Rolls-Royce Nuclear Submarines in 2023. His first substantive role was as Head of Security and Resilience within the Licence Authority Team. Prior to then taking on Head of program for AUKUS, Ed was seconded to the Chief of Staff position for Rolls-Royce Submarines. Prior to joining the submarine business, Ed was a career solider serving 10 years with the New Zealand Defense Force with the 1st NZ Special Air Service (SAS) Gp before transitioning to the British Army where he served another 22 years with the 22nd British SAS Regiment before retiring as a senior Officer. Ed holds a master’s degree in security and risk management, is certified with the World institute for nuclear security (WINS) as a Certified Nuclear Security Specialist, is a chartered member with the security professional resister (CsyP) and was awarded the Conspicuous Gallantry Cross during an offensive action operation in Afghanistan in 2001.
Sebastien Bouchard
Operator, POV
Operator, POV
Sebastien Bouchard
Sebastien Bouchard is a former Special Operations Forces operator and founding member of the Canadian Special Operations Regiment (CSOR). He joined the Canadian Armed Forces in 2000, motivated by a sense of service and a longing for challenge. Over his career, he completed ten operational deployments—including seven combat missions—in places like Afghanistan, Iraq, and Northern Africa.
Rising to the rank of Warrant Officer, Sebastien served as Head Instructor of CSOR’s Sniper Program, where he trained and mentored elite marksmen. Today, he leads a global special risk mitigation firm, applying his operational experience, leadership, and strategic insight to provide discreet, high-impact solutions to complex global challenges.
Daniel David Corbett III
Operator POV
Operator POV
Daniel David Corbett III
Daniel Corbett is a former U.S. Navy SEAL operator who served with elite units including SEAL Teams 5, 6, and 17. Enlisting in 2002, he deployed to Iraq and later joined SEAL Team 6, executing global missions in some of the world’s most challenging environments.
After transitioning from active duty, Daniel instructed future SEALs at the Naval Special Warfare Basic Training Command and later applied his expertise in the private sector, supporting complex international operations. His 2017 imprisonment in Serbia while on assignment became the subject of his best-selling memoir, American Mercenary, now in development as a television series.
Today, Daniel continues to lead entrepreneurial and strategic initiatives focused on unconventional solutions to global security challenges.
LEARN MORE ABOUT HOW DEZAWA MUSECELLS® CAN TRANSFORM YOUR RECOVERY.
Get in touch with a qualified DHP representative to learn about solutions available to you.
All legitimate Dezawa MuseCells® supplied to any market must originate from MCI’s manufacturing ecosystem and must be distributed through MCI-designated, licensed partners. This structure ensures that every Dezawa MuseCells® product regardless of country of delivery meets the highest scientific, ethical, and quality standards established by MCI and validated with ongoing global clinical research. Dezawa MuseCells® require licensed, high-purity (≥70% SSEA-3⁺) enrichment and rigorous manufacturing that cannot be performed cheaply, so any low-cost product is simply unpurified MSCs mislabeled as Muse and cannot deliver true Muse-cell effects and may have potential side effects.
FREQUENTLY ASKED QUESTIONS
How long does it take to see results from Dezawa MuseCells® therapy?
Recovery timelines can vary based on individual factors and the intensity of physical activity. Many users report improvements in tissue repair, reduced inflammation, and faster rebound within days to weeks, while long-term regenerative benefits may accumulate over multiple sessions. Dezawa MuseCells® are designed to persist in damaged tissue, providing ongoing cellular support for sustained recovery.
Can Dezawa MuseCells® therapy help with overuse injuries?
Yes. Dezawa MuseCells® target micro-damage sites caused by repetitive stress on muscles, joints, tendons, and connective tissue. By homing to these areas and supporting cellular repair, the therapy can reduce downtime and improve tissue durability, making it suitable for athletes or Warfighters experiencing chronic strain from repeated activity.
Are Dezawa MuseCells® therapies suitable for older adults or aging athletes?
Dezawa MuseCells® are naturally stress-resistant and pluripotent-like adult stem cells, making them adaptable across a wide range of ages. While younger, high-performance users benefit from accelerated recovery, older adults may also experience support for tissue maintenance, reduced inflammation, and joint health, helping extend functional longevity.
How do Dezawa MuseExosomes® complement Dezawa MuseCells® in the Regenisis IV?
MuseExosomes® are cell-derived signaling vesicles that enhance the body’s regenerative response. When combined with Dezawa MuseCells® in the Restore IV:
- Inflammation is reduced more quickly.
- Tissue stabilization is improved in areas of trauma.
- Cellular communication is enhanced, supporting coordinated repair.
- This makes the Regenisis IV Therapy especially effective for higher-intensity interventions after injury or accumulated stress.
Can Dezawa MuseCells® therapy be used alongside other recovery methods?
Yes. Dezawa MuseCells® therapy is designed to integrate seamlessly with the body, making it compatible with complementary recovery approaches such as physical therapy, nutrition, and controlled training protocols. Combining therapies may optimize tissue repair, reduce inflammation, and accelerate functional recovery, though treatments should be guided by a qualified clinical partner.
What makes Dezawa MuseCells® different from other regenerative therapies?
Dezawa MuseCells® therapies stand out due to:
- Stress endurance: Cells survive harsh tissue environments.
- Targeted homing: They locate and repair micro-damaged areas.
- Low immune clearance: Reduced risk of rejection or inflammation.
- Broad regenerative potential: They support multiple tissue types, including muscles, tendons, ligaments, and vascular structures.
These features differentiate them from conventional stem cells.
Are Dezawa MuseCells® therapies clinically supported?
Yes. Dezawa MuseCells® are backed by over a decade and a half of research, over 85 peer-reviewed studies, and 120+ global publications. Clinical evidence demonstrates their safety, immune tolerance, and regenerative potential across multiple tissue types. They are produced under rigorous quality standards to ensure reproducible and predictable outcomes in high-performance recovery.